Immunogenicity and Safety of the Quadrivalent Adjuvant Subunit Influenza Vaccine in Seropositive and Seronegative Healthy People and Patients with Common Variable Immunodeficiency.
Mikhail P KostinovElena A LatyshevaAristitsa Mikhailovna KostinovaNelly K AkhmatovaTatyana V LatyshevaAnna E VlasenkoYulia A DagilEkaterina A KhromovaValentina B PolichshukPublished in: Vaccines (2020)
Adjuvant QIV promotes formation of specific immunity to vaccine strains, regardless of antibodies' presence or absence before. In CVID patients search of new regimens should be continued.